methyl 5-aminolevulinate has been researched along with clobetasol in 2 studies
| Studies (methyl 5-aminolevulinate) | Trials (methyl 5-aminolevulinate) | Recent Studies (post-2010) (methyl 5-aminolevulinate) | Studies (clobetasol) | Trials (clobetasol) | Recent Studies (post-2010) (clobetasol) |
|---|---|---|---|---|---|
| 524 | 152 | 319 | 1,532 | 389 | 593 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Petersen, B; Wiegell, SR; Wulf, HC | 1 |
| Johansen, UB; Wiegell, SR; Wulf, HC | 1 |
2 trial(s) available for methyl 5-aminolevulinate and clobetasol
| Article | Year |
|---|---|
Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents; Clobetasol; Erythema; Facial Dermatoses; Female; Fluoroscopy; Glucocorticoids; Humans; Keratosis, Actinic; Male; Pain; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp Dermatoses; Treatment Outcome | 2014 |
Pulse-Daylight-Photodynamic Therapy in Combination with Corticosteroid and Brimonidine Tartrate for Multiple Actinic Keratoses: A Randomized Clinical Trial.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adrenergic alpha-2 Receptor Agonists; Aminolevulinic Acid; Brimonidine Tartrate; Clobetasol; Denmark; Erythema; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Time Factors; Treatment Outcome | 2019 |